Literature DB >> 2940862

Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk.

L A Farrer.   

Abstract

Suicide behavior in Huntington disease (HD) was assessed by examining the proportion of deaths attributed to suicide among 452 deceased individuals with HD and the number and pattern of attempted suicides among a total population of 831 HD patients from the National Huntington Disease Research Roster. It was found that 5.7% of deaths among affected persons resulted from suicide and 27.6% of patients attempted suicide at least once. Comparison of this group with the general population indicated that the proportion of deaths due to suicide among persons with HD is almost four times greater than the corresponding proportion for the U.S. Caucasian population. Age at onset of HD was not significantly different between HD suicide and non-suicide patients, although suicide occurred more frequently in the early to middle stages of the illness. The "success" rate among HD suicide attempters did not differ from the general population rates in several western European countries. The relatively high suicide and attempted suicide rates in HD indicate that thorough psychological testing of at-risk persons and extensive patient support systems must be integral components of a program to identify HD gene carriers using a genetic marker.

Entities:  

Mesh:

Year:  1986        PMID: 2940862     DOI: 10.1002/ajmg.1320240211

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  36 in total

Review 1.  Psychological impact of genetic testing for Huntington's disease: an update of the literature.

Authors:  B Meiser; S Dunn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 2.  Psychological effect of genetic testing for Huntington's disease: an update of the literature.

Authors:  B Meiser; S Dunn
Journal:  West J Med       Date:  2001-05

3.  Huntington's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

4.  Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.

Authors:  K Lawson; S Wiggins; T Green; S Adam; M Bloch; M R Hayden
Journal:  J Med Genet       Date:  1996-10       Impact factor: 6.318

Review 5.  Huntington's disease genetics.

Authors:  Richard H Myers
Journal:  NeuroRx       Date:  2004-04

6.  Depression and suicidal ideation after predictive testing for Huntington's disease: a two-year follow-up study.

Authors:  Maria U Larsson; Mary A Luszcz; The-Hung Bui; Tarja-Brita Robins Wahlin
Journal:  J Genet Couns       Date:  2006-10       Impact factor: 2.537

7.  Suicidal ideation in Huntington disease: the role of comorbidity.

Authors:  Heather H Wetzel; Carissa R Gehl; Lisa Dellefave-Castillo; Judith F Schiffman; Kathleen M Shannon; Jane S Paulsen
Journal:  Psychiatry Res       Date:  2011-05-24       Impact factor: 3.222

8.  Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.

Authors:  Samuel Frank
Journal:  BMC Neurol       Date:  2009-12-18       Impact factor: 2.474

Review 9.  Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?

Authors:  R M Bonelli; H-P Kapfhammer; S S Pillay; D A Yurgelun-Todd
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

10.  Suicide risk in Huntington's disease.

Authors:  L Di Maio; F Squitieri; G Napolitano; G Campanella; J A Trofatter; P M Conneally
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.